Search for tag: "inhibitor"

John Brognard - Tracking down the elusive dark kinome to identify new cancer drug targets

Tony Hunter 50th Symposium

+18 More
From  Mike Jeffs

Ruth Palmer - What model organisms have taught us about the role of the ALK receptor tyrosine kinase in human neuroblastoma

Tony Hunter 50th Symposium

+18 More
From  Mike Jeffs

Susan Taylor - How elucidating the structure of the protein kinase A catalytic domain has enabled the development of selective kinase inhibitors

Tony Hunter 50th Symposium

+19 More
From  Mike Jeffs

Manish Butte - Overcoming metabolic and immunological limitations of the tumor microen vironment

LJIC 2024

+18 More
From  Mike Jeffs

John Teijaro - Modulating cytokine signaling networks to control persistent viral infections and cancer

LJIC 2024

+18 More
From  Mike Jeffs

Tony Hunter - Oncogenes and Cell Signaling

UCSD Cancer Course.

+19 More
From  jmcdonagh

Tony Hunter – Oncogenes and Cell Signaling

+19 More
From  jmcdonagh

Tony Hunter – Oncogenes and Cell Signaling

+19 More
From  jmcdonagh

Tony Hunter – Salk Cancer Course (BGGN 245) Targeting deregulated protein phosphorylation pathways in cancer therapy

+19 More
From  jmcdonagh

Benjamin Cravatt – Activity-Based Proteomics — Applications For Enzyme and Inhibitor Discovery

+19 More
From  jmcdonagh